Edition:
United States

Inovalon Holdings Inc (INOV.OQ)

INOV.OQ on NASDAQ Stock Exchange Global Select Market

14.70USD
14 Dec 2017
Change (% chg)

$-0.15 (-1.01%)
Prev Close
$14.85
Open
$14.90
Day's High
$14.95
Day's Low
$14.65
Volume
86,502
Avg. Vol
112,455
52-wk High
$17.80
52-wk Low
$8.60

Summary

Name Age Since Current Position

Keith Dunleavy

47 2006 Chairman of the Board, Chief Executive Officer

Robert Wychulis

62 2014 President

Christopher Greiner

41 2016 Chief Financial Officer, Chief Operating Officer

Daniel Mendelson

52 2000 President of Avalere Health

Christopher Hand

56 2016 Chief Growth Officer

Shauna Vernal

47 2013 Chief Legal Officer, Corporate Secretary

Denise Fletcher

68 2012 Independent Director

William Green

63 2016 Independent Director

Andre Hoffmann

58 2008 Independent Director

Lee Roberts

64 2012 Independent Director

William Teuber

65 2013 Independent Director

Biographies

Name Description

Keith Dunleavy

Dr. Keith R. Dunleavy, M.D. is Chairman of the Board, Chief Executive Officer of the company. Dr. Dunleavy has served as our Chief Executive Officer since his organization of our predecessor companies in 1998, as Chairman of the Board since the creation of the Board in 2006, and as President from our foundation until May of 2014. Dr. Dunleavy is responsible for the overall execution of our business plan, strategic relationships, and the identification and realization of our product strategy and vision. During his tenure building Inovalon, Dr. Dunleavy has worked extensively with a wide array and number of healthcare organizations, regulatory and oversight bodies, and technology companies examining the growing role of data within healthcare, and its ability to drive meaningful insight and improvement for its constituents. Dr. Dunleavy serves as a Director on the Dartmouth Medical School Board of Overseers, has authored or co-authored a number of scientific journal articles, abstracts, and proprietary research papers, and has presented his work and materials at multiple national and international conferences. Dr. Dunleavy received a Bachelor's degree in Biology modified with Engineering with High Honors from Dartmouth College, where his studies and work focused upon the neurosciences, computer sciences and engineering and his honors thesis focused on the computer simulation of artificial human cerebellar functional units. He earned his doctorate in medicine from Harvard Medical School, completed his medical residency at The Johns Hopkins Hospital in Baltimore, Maryland, and practiced and was Board Certified in Internal Medicine.

Robert Wychulis

Mr. Robert A. Wychulis is President of the company. Mr. Wychulis serves as the general manager of the company, ultimately responsible for all aspects of the company's goals and commitments around day-to-day product and service delivery, performance, support, and client value achievement. Prior to joining Inovalon, from 2008 to May 2014, Mr. Wychulis served as the President of the WellPoint New York government program health plan, HealthPlus, an Amerigroup company, where he was responsible for the management of the company's product portfolio within the New York region. Prior to joining WellPoint/Amerigroup, from 2003 to 2008, Mr. Wychulis served as President and CEO of the Florida Association of Health Plans, where he grew the association from eight to 26 plans in four years. From 1995 to 2002, Mr. Wychulis served as President and CEO of HealthPlan Southeast, a North Florida managed care company comprised of state employee, commercial and Medicaid/CHP contracts. Mr. Wychulis received his Bachelor of Political Science degree from the City College of New York and his Masters of Health Administration and Planning from the Wagner School of Public Administration at New York University.

Christopher Greiner

Mr. Christopher E. Greiner serves as Chief Financial Officer, Chief Operating Officer of the Company. Mr. Greiner is responsible for managing and overseeing the implementation, service delivery, performance and reporting of all of our developed product and solution groups of the company. Prior to joining Inovalon as Chief Product Officer in May 2013, from November 2012 to April 2013, Mr. Greiner served as a Vice President at Computer Sciences Corporation, where he was responsible for financial management of the company's commercial portfolio. From April 1999 to November 2012, Mr. Greiner served as the combined Chief Operating Officer and Chief Financial Officer of IBM's Business Analytics division, formally known as Cognos. Prior to this position, Mr. Greiner was responsible for IBM's global services business based in Shanghai, China, and Tokyo, Japan. Additionally, Mr. Greiner fulfilled multiple roles in finance and operations both within IBM's U.S. business and overseas operations in Australia, India, China, Hong Kong, Taiwan, and Singapore. Mr. Greiner received a Bachelor of Business Administration in Finance and Economics from Baylor University.

Daniel Mendelson

Mr. Daniel N. Mendelson is President of Avalere Health of the Company. Mr. Dan Mendelson has served as President of Avalere Health, a subsidiary of Inovalon acquired in September 2015. Avalere is a vibrant community of innovative thinkers dedicated to solving the challenges of the healthcare system through data-driven advisory services and business intelligence products. As President of Avelere, Mr. Mendelson leads the organization's focus on bringing data-enabled strategic guidance and tools to the full array of healthcare companies – from pharmaceuticals and life sciences, to managed care and providers. Mr. Mendelson presently serves on the Board of Champions Oncology (CSBR) and is on the faculty of the Wharton School of Business at the University of Pennsylvania. He previously served on the boards of Coventry Healthcare (sold to Aetna in 2013), PharMerica Corporation (PMC) and HMS holdings (HMSY). Mr. Mendelson has published widely in peer-reviewed and professional journals on health information technology, the costs of disease, hospital costs and operations, physician payment, the economics of managed care, medical malpractice and a range of other topics. He holds an undergraduate degree in economics and viola performance from Oberlin College, and a Masters in Public Policy from the Kennedy School of Government at Harvard University.

Christopher Hand

Mr. Christopher Hand is Chief Growth Officer of the Company. Mr. Hand is responsible for the design and execution of the overall business development of the Company and its affiliates, inclusive of sales, marketing, go-to-market strategies, channel relationships, strategic partnerships and alliances. Prior to joining Inovalon, Mr. Hand served as Senior Vice President of Sales at Dealertrack Technologies from 2014 to 2015, a $1 billion cloud-based software-as-a-service (SaaS) solutions and services provider. Prior to Dealertrack, Mr. Hand served at Hewlett Packard's Enterprise Services, a $23 billion global division of HP, as Vice President, Worldwide Enterprise Strategic Cloud Sales from 2011 to 2014. In this role, Mr. Hand was responsible for expanding and leading the global strategic sales campaign and channels to market for HP Enterprise Services' Hybrid Cloud Solutions. Prior to his tenure at HP, Mr. Hand served as Senior Vice President, Worldwide Sales and on the Operating Committee including Mobile Cloud SaaS solution sales for Motricity from 2009 to 2011, and previously held strategic sales leadership positions at Avaya, Alcatel, 3COM and the Timeplex division of Unisys. Mr. Hand received his Bachelor's Degree from Syracuse University, Whitman Business School in Business Marketing and Personnel Management and has completed Leadership Best Practices, PLD Program for Leadership Development, Changing the Game-Decision Making and Aligning Sales and Strategy at Harvard Business School – Executive Education.

Shauna Vernal

Ms. Shauna L. Vernal is no longer Chief Legal Officer, Corporate Secretary of the company effective December 31, 2017. she holds responsibility for the planning, management, execution, and oversight of all legal, liability, regulatory, intellectual property, and risk management matters across all aspects of the company. Prior to joining Inovalon, Ms. Vernal served as Chief Legal Officer for Falck USA, a large provider of emergency medical services, from April 2012 to April 2013, where she oversaw all legal aspects of Falck USA's operations, including mergers and acquisitions and other strategic matters. Prior to her tenure at Falck, from September 2000 to March 2012, Ms. Vernal served in various senior strategic legal roles at Microsoft Corporation, including, for nearly nine years, mergers and acquisitions, corporate governance, and securities matters, and lastly, serving as the lead attorney and part of the leadership team for Microsoft's Worldwide Public Sector. Prior to her tenure at Microsoft, from January 1998 to August 2000, Ms. Vernal served as Senior Vice President, Chief Legal Officer, and Corporate Secretary of West Coast Bancorp. Ms. Vernal began her career as an attorney at the law firm of Graham & Dunn, P.C. in Seattle, Washington. Ms. Vernal received her Juris Doctorate with honors from the University of Washington and her Bachelors of Business Administration, Summa Cum Laude, from California Lutheran University. She also graduated with Honors from Pacific Coast Banking School, executive business management training for financial institution executives and regulators.

Denise Fletcher

Ms. Denise K. Fletcher is Independent Director of the company. Ms. Fletcher is a former Executive Vice President, Finance of Vulcan Inc., an investment and project company organized by Microsoft co-founder Paul Allen, a position she held from 2005 to 2008. From 2004 to 2005, she served as Chief Financial Officer of DaVita, Inc., a provider of dialysis services in the United States. From 2000 to 2003, she was Executive Vice President and Chief Financial Officer of MasterCard International, an international payment solutions company. Before joining MasterCard, she served as Chief Financial Officer of Bowne Inc., a global document management and information services provider. Ms. Fletcher is a director of Unisys, a worldwide information technology company, and a member of the supervisory board of Mazars Group, an international organization that specializes in audit, accounting, tax, legal, and advisory services. During 2004 and 2005, she served as a director of Sempra Energy and of Orbitz, Inc. Ms. Fletcher graduated Phi Beta Kappa from Wellesley College and received her master's degree from Harvard University

William Green

Mr. William D. Green is Independent Director of the Company. Mr. Green is slated to serve as a director of the Board at Denali Holding Inc., the parent company of Dell, Inc., a global computer and data storage technology and services company, where he is to serve on the Audit Committee and the Capital Stock Committee of the Board. Mr. Green also serves on the Board of Directors for S&P Global, Inc. (NYSE: SPGI) (previously known as McGraw Hill Financial, Inc.), a global financial information and services company, where he serves on both the Compensation and Leadership Development Committee and the Nominating and Corporate Governance Committee. While at Accenture (NYSE: ACN), a global management consulting, technology services and outsourcing company, Mr. Green held multiple key roles. After joining Accenture in 1977 and becoming a partner in 1986, he went on to serve in multiple roles including chief operating officer and the chief executive of the resource operating group, and ultimately went on to serve as the company’s chief executive officer from September 2004 through December 2010, and chairman of the board from 2006 to 2013. Mr. Green also serves as lead director of EMC Corporation’s (NYSE: EMC) Board of Directors, where he serves on the Audit, Leadership and Compensation and Mergers and Acquisitions committees, until the closing of its acquisition by Denali Holding Inc., the parent company of Dell, Inc. Mr. Green attended Dean College and is a member of the college’s Board of Trustees. He received a Bachelor of Science degree in Economics and a Master of Business Administration from Babson College as well as an Honorary Doctor of Laws.

Andre Hoffmann

Mr. Andre S. Hoffmann is Independent Director of the company. Mr. Hoffmann has served as a director of Inovalon since 2008. Since 2006, Mr. Hoffmann has served as the Vice Chairman of the board of Roche Holding, Ltd., one of the world's largest diversified healthcare companies focused on medical diagnostics and treatments, and has served as a board member since 1996. Mr. Hoffmann served as Non-Executive Vice Chairman of Givaudan SA, the world's leading flavor and fragrance company, from 2008 to 2016, and as a non-executive member of the Board from 2000 to 2016. Since 1999, Mr. Hoffmann also has served as the Chairman and owner of Massellaz S.A., a research and advisory company, and, from 2005 to 2013, served as the Chairman and owner of Nemadi Advisors Ltd., a private equity advisory company. Mr. Hoffmann also serves as a director for Genentech Inc., one of the world's largest biotechnology companies and a subsidiary of Roche, Amazentis SA, a private therapeutics and diagnostics company, and Glyndebourne Productions Ltd., a service company.

Lee Roberts

Mr. Lee D. Roberts is Independent Director of the company. Mr. Roberts has served as President and Chief Executive Officer of Bluewater Consulting, an information technology management consulting company. From 2006 to 2008, Mr. Roberts was the Vice President and General Manager, IBM Document & Content Management for IBM Corporation. In 2006, IBM acquired FileNET Corporation, where Mr. Roberts had served as President and Chief Executive Officer from 1997 through 1999, and as Chairman and Chief Executive Officer from 2000 until its acquisition in 2006. Mr. Roberts currently serves on the boards of QAD, Inc., a publicly-traded provider of enterprise resource planning and supply chain software, and Unisys, a worldwide information technology company. Mr. Roberts has also served on the boards of a number of other public and private companies, including, most recently, Varolii Corporation, a privately-held provider of on-demand communications software services. Mr. Roberts earned Bachelor's degrees in Economics, Biology, and Chemistry at California State University, San Bernardino and his MBA degree with honors at the University of California, Riverside. He completed IBM's Executive International Management Program in Belgium and Executive Management Development programs at Harvard University.

William Teuber

Mr. William J. Teuber Jr. is Independent Director of the company. Mr. Teuber has served as a director of Inovalon since 2013. Since 2006, Mr. Teuber has served as Vice Chairman of EMC Corporation, a world leader in information infrastructure technology, big data, cloud computing, and data security solutions. From 2006 to 2012, Mr. Teuber oversaw EMC Customer Operations, EMC's global sales and distribution organization. Mr. Teuber additionally serves as a member of the board of Pivotal Software, a big data and cloud computing company and member of the EMC federation structure. Prior to being appointed Vice Chairman of EMC, Mr. Teuber served as Chief Financial Officer of EMC from 1996 to 2006, where he was responsible for leading EMC's worldwide finance operation. Prior to joining EMC, Mr. Teuber was a partner in the Audit and Financial Advisory Services practice of Coopers & Lybrand L.L.P. from 1988 to 1995. Mr. Teuber is the lead director of Popular, Inc., a diversified financial services company that includes Banco Popular as a holding. He is also a Trustee of the College of the Holy Cross. Mr. Teuber holds a Master of Business Administration from Babson College, a Master of Science in Taxation from Bentley College, and a Bachelor's degree from the College of the Holy Cross.

Basic Compensation

Name Fiscal Year Total

Keith Dunleavy

210,269

Robert Wychulis

712,034

Christopher Greiner

2,188,000

Daniel Mendelson

--

Christopher Hand

--

Shauna Vernal

489,963

Denise Fletcher

182,507

William Green

147,514

Andre Hoffmann

182,507

Lee Roberts

182,507

William Teuber

182,507
As Of  30 Dec 2016